Trial Profile
Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- Acronyms ILIST
- 26 Mar 2014 Trial status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
- 20 Aug 2013 New trial record